SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cytokinetics, Incorporated ( CYTK)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
405 30 0 CYTK
Emcee:  mopgcw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
280Cytokinetics, Incorporated Reports Third Quarter 2009 Financial Results Quarterlmopgcw-10/29/2009
279Amgen Inc (AMGN) (60.45 +0.18) Cytokinetics Inc (CYTK) (5.18 +0.20) NEW YORK (Domopgcw-9/29/2009
278Chuckle, and all based on something that is, I don't know, how many years domopgcw-9/22/2009
277>> from $4 to $18 << It's these small, incremental changes thatscaram(o)uche-9/21/2009
276Wedbush Morgan Maintains an 'Outperform' on Cytokinetics (CYTK); Raises mopgcw-9/21/2009
275--------------------------------------------------------------------------------mopgcw-9/18/2009
274CS: Cytokinetics Inc. (CYTK) OUTPERFORM [V] M. Aberman CP: US$ 3.52 TP: US$ 7 CAmopgcw-9/18/2009
273seeking alpha Cash for Cardiovascular: Who Might Be Next? August 12, 2009 By Mimopgcw-8/12/2009
272CS: Cytokinetics Inc. (CYTK) OUTPERFORM [V] M. Aberman CP: US$ 2.97 TP: US$ 7 CAmopgcw-7/31/2009
271CS: Cytokinetics Inc. (CYTK) OUTPERFORM [V] M. Aberman CP: US$ 2.70 TP: US$ 6 CAmopgcw-6/18/2009
270>>Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presentetuck-6/1/2009
269OT-Could you please refrain in the future from using the words "wife" kenhott-5/27/2009
268True, I knew it all along, and true CYTK probably had a view about AMGN's prmopgcw-5/27/2009
267Well you knew and I knew AMGN would opt in. :) I am suggesting that CYTK SHOULkenhott-5/27/2009
266I think Tuck is spot on as it is still a big unknown, and was not clear whether mopgcw-5/27/2009
265OT- Gain = Always Good. It will be challenging for me to figure out if this stkenhott-5/27/2009
264I'm a little disappointed with the market's reaction, but deep down, evetuck-5/27/2009
263Why did CYTK go for more cash right before the opt-in? As far as I know, it waskenhott-5/27/2009
262CS: Cytokinetics Inc. (CYTK) OUTPERFORM [V] M. Aberman CP: US$ 2.08 TP: US$ 6 CAmopgcw-5/26/2009
261>>Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiatuck-5/26/2009
260News re: AMGN deal 9am today. PR must be coming. edit: AMGN exercises right tokenhott-5/26/2009
259CS: Cytokinetics Inc. (CYTK) OUTPERFORM [V] M. Aberman CP: US$ 1.97 TP: US$ 6 CAmopgcw-5/19/2009
258cc: Cytokinetics, Inc. Q1 2009 Earnings Call Transcript April 30, 2009 4:30 pmmopgcw-5/8/2009
257SeekingAlpha: Cytokinetics, Inc. Q1 2009 Earnings Call Transcript April 30, 20mopgcw-5/5/2009
2563rd Q PR. Nothing new, but some data presentations upcoming, one soon . . tuck-4/30/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News